Charles River Laboratories International (CRL) Earnings Date, Estimates & Call Transcripts $154.81 -2.57 (-1.63%) As of 10:44 AM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Earnings Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock Charles River Laboratories International Earnings Summary Charles River Laboratories International announced Q2 2025 earnings on August 6, 2025, reporting an EPS of $3.12, which beat analysts' consensus estimates of $2.50 by $0.62. Quarterly revenue rose .6% year-over-year to $1.03 billion, above the consensus estimate of $983.76 million. With a trailing EPS of -$1.33, Charles River Laboratories International's earnings are expected to grow 17.52% next year, from $9.36 to $11.00 per share. Upcoming Q3 Earnings DateNov. 5Before Market OpensEstimatedConsensus EPS (Aug. 6) $2.50 Actual EPS (Aug. 6) $3.12 Beat By $0.62 Actual Revenue (Aug. 6) $1.03BQ2 2025 Earnings ResourcesQ2 2025 Earnings ReportConference Call Transcript & Audio Press Release (8-K) Slide Deck Quarterly Report (10-Q)SEC FilingCRL Upcoming EarningsCharles River Laboratories International's next earnings date is estimated for Wednesday, November 5, 2025, based on past reporting schedules. Slide DeckFull Screen Slide DeckPowered by Get Charles River Laboratories International Earnings Alerts Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Charles River Laboratories International and other key companies, straight to your inbox. Sign Up View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Skip Charts & View Estimated and Actual Earnings DataCRL Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.CRL Estimated and Actual Revenue by QuarterEstimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. Charles River Laboratories International Analyst EPS EstimatesQuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateRevenue EstimateCompany EPS GuidanceCompany Revenue GuidanceQ1 20252$2.06$2.06$2.06Q2 20252$2.49$2.49$2.49Q3 20251$2.44$2.44$2.44Q4 20251$2.52$2.52$2.52 FY 2025 6 $9.51 $9.51 $9.51 Q1 20261$2.74$2.74$2.74Q2 20261$2.74$2.74$2.74Q3 20262$2.48$2.63$2.56Q4 20262$2.46$2.72$2.59 FY 2026 6 $10.42 $10.83 $10.63 Q1 20271$2.88$2.88$2.88 Charles River Laboratories International Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years 10 Years Time Frame Start Date End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails 11/5/2025(Estimated)--------8/6/2025Q2 2025$2.50$3.12+$0.62$1.06$983.76M$1.03B5/7/2025Q1 2025$2.06$2.34+$0.28$0.50$942.34M$984.17M2/19/2025Q4 2024$2.50$2.66+$0.16-$4.22$983.63M$1.00B11/6/2024Q3 2024$2.43$2.59+$0.16$3.85$975.99M$1.01B8/7/2024Q2 2024$2.39$2.80+$0.41$3.86$1.03B$1.03B5/9/2024Q1 2024$2.05$2.27+$0.22$3.24$997.24M$1.01B2/14/2024Q4 2023$2.39$2.46+$0.07$1.30$991.25M$1.01B11/8/2023Q3 2023$2.35$2.72+$0.37$3.75$1.00B$1.03B Charles River Laboratories International Earnings - Frequently Asked Questions When is Charles River Laboratories International's earnings date? Charles River Laboratories International has not confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, November 5th, 2025 based off last year's report dates. Learn more on CRL's earnings history. What guidance has Charles River Laboratories International issued on next quarter's earnings? Charles River Laboratories International issued an update on its FY 2025 earnings guidance on Thursday, August, 7th. The company provided earnings per share guidance of 9.900-10.300 for the period, compared to the consensus EPS estimate of 9.600. The company issued revenue guidance of $3.9 billion-$4.0 billion, compared to the consensus revenue estimate of $3.9 billion. Did Charles River Laboratories International beat their earnings estimates last quarter? In the previous quarter, Charles River Laboratories International (NYSE:CRL) reported $3.12 earnings per share (EPS) to beat the analysts' consensus estimate of $2.50 by $0.62. Learn more on analysts' earnings estimate vs. CRL's actual earnings. How can I listen to Charles River Laboratories International's earnings conference call? The conference call for Charles River Laboratories International's latest earnings report can be listened to online. Listen to Conference Call How can I read Charles River Laboratories International's conference call transcript? The conference call transcript for Charles River Laboratories International's latest earnings report can be read online. Read Transcript How can I view Charles River Laboratories International's earnings report? Charles River Laboratories International's earnings report can be found in their filing with the SEC. View SEC filing How much revenue does Charles River Laboratories International generate each year? Charles River Laboratories International (NYSE:CRL) has a recorded annual revenue of $4.03 billion. How much profit does Charles River Laboratories International generate each year? Charles River Laboratories International (NYSE:CRL) has a recorded net income of $22.20 million. CRL has generated -$1.33 earnings per share over the last four quarters. What is Charles River Laboratories International's price-to-earnings ratio? Charles River Laboratories International (NYSE:CRL) has a forward price-to-earnings ratio of 16.90. The price/earnings-to-growth ratio is 5.18. What is Charles River Laboratories International's EPS forecast for next year? Charles River Laboratories International's earnings are expected to grow from $9.36 per share to $11.00 per share in the next year, which is a 17.52% increase. More Earnings Resources from MarketBeat Related Companies ICLR Earnings Results TECH Earnings Results IQV Earnings Results MTD Earnings Results WAT Earnings Results ILMN Earnings Results BIO Earnings Results BRKR Earnings Results PACB Earnings Results TMO Earnings Results Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Latest Articles Why DocuSign Could Be a SaaS Value Play After Q2 EarningsAffirm Crushes Earnings Expectations, Turns Bears into BelieversAmbarella's Earnings Prove Its Edge AI Strategy Is a WinnerWhat to Watch for From D-Wave Now That Earnings Are DoneDICKS’s Sporting Goods Stock Dropped After Earnings—Is It a Buy?NVIDIA's Earnings Show a Green Light for Taiwan Semiconductor After Earnings Miss, Walmart Is Still a Top Consumer Staples Play This page (NYSE:CRL) was last updated on 9/10/2025 by MarketBeat.com Staff From Our PartnersStunning new initiative unfolding in the White House?what I just learned about what’s unfolding in the White House is truly stunning… And you need to see it for...Paradigm Press | SponsoredTrump's Law S.1582: $21T Dollar Revolution ComingDo you have money in any of these banks? Chase. Bank of America. Citigroup. Wells Fargo. U.S. Bancorp. I...Brownstone Research | Sponsored“Fed Proof” Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredTrump’s national nightmare is herePorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | SponsoredWorld War 3? Everything Just Changed — and One Tiny Company Is at the Center of It.Trump immediately activated a $5.3 TRILLION AI missile shield — code-named Golden Dome — to stop drone swarms ...Angel Publishing | SponsoredTime is running out on the most obvious trade in historyGold just broke out to fresh all-time highs, silver is up 40% this year, and for the first time in three decad...Golden Portfolio | Sponsored“HELIOS”: My No. 1 Investment of the 2020sA mysterious new energy technology — backed by Nvidia, Google, and even legendary investors like Stanley Druck...Stansberry Research | Sponsored2013 Bitcoin miner reveals his trading system (free)There are 18,347 cryptocurrencies in the market right now. 99% of them will fail. And trying to pick winner...Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Charles River Laboratories International, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Charles River Laboratories International With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
